Robust in vivo expansion and long-term persistence of anti-BCMA CAR T cells, PHE885, manufactured in <2 days on the T-Charge platform
Shuntaro Ikegawa,Rao Prabhala,Adam Sperling,Sarah Nikiforow,David Quinn,Dexiu Bu,Jennifer Mataraza,David Pearson,Lawrence Rispoli,Marc Credi, Nina Orwitz, Laksmi Potluri,Yohei Arihara,Carol Reynolds,Michela Ansuinelli,Tuyet Nguyen, Serena Vita,Nikhil Munshi,Jerome Ritz CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
AI 理解论文
溯源树
样例
